To examine whether PRMT3 catalytic activity confers altered HCC glycolysis and growth, we conducted further studies using PRMT3‐wild‐type (WT) and catalytic inactive mutant PRMT3‐E338Q (Figure 5A).28, 29. The gene discussed is PRMT3; the disease is hepatocellular carcinoma.